STOCK TITAN
  1. Home
  2. Sec-filings
  3. GRI
  4. [EFFECT] GRI Bio, Inc. SEC Filing

[EFFECT] GRI Bio, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 30, 2026 4:05 P.M.
Form: S-3
CIK: 0001824293
Company Name: GRI Bio, Inc.
File Number: 333-293065

Source: View Original Filing on SEC EDGAR

GRI Bio

NASDAQ:GRI

View GRI Stock Overview →

GRI Rankings

#6808 Ranked by Market Cap
N/A Ranked by Dividends

GRI Latest News

Feb 17, 2026
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment
Feb 5, 2026
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
Feb 4, 2026
GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights
Jan 28, 2026
GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF
Jan 26, 2026
GRI Bio Secures New U.S. Composition of Matter Patent Covering Novel Compound Structures

GRI Latest SEC Filings

Feb 13, 2026
[SCHEDULE 13G/A] GRI Bio, Inc. Amended Passive Investment Disclosure
Feb 10, 2026
[SCHEDULE 13G/A] GRI Bio, Inc. Amended Passive Investment Disclosure
Feb 4, 2026
[8-K] GRI Bio, Inc. Reports Material Event
Jan 30, 2026
[10-K] GRI Bio, Inc. Files Annual Report
Jan 29, 2026
[424B5] GRI Bio, Inc. Prospectus Supplement (Debt Securities)

GRI Stock Data

3.77M
1.44M
Biotechnology
Pharmaceutical Preparations
Link
United States
LA JOLLA